PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 146 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2019. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $74,868 | -12.5% | 24,229 | +19.8% | 0.00% | 0.0% |
| Q4 2022 | $85,522 | -25.0% | 20,218 | +63.2% | 0.00% | -50.0% |
| Q2 2021 | $114,000 | +11.8% | 12,385 | +17.5% | 0.00% | 0.0% |
| Q1 2021 | $102,000 | -5.6% | 10,539 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $108,000 | +1.9% | 10,539 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $106,000 | -3.6% | 10,539 | 0.0% | 0.01% | -25.0% |
| Q2 2020 | $110,000 | +23.6% | 10,539 | 0.0% | 0.01% | +14.3% |
| Q1 2020 | $89,000 | -80.9% | 10,539 | -80.2% | 0.01% | -82.9% |
| Q4 2019 | $466,000 | -32.9% | 53,289 | -17.4% | 0.04% | -35.9% |
| Q3 2019 | $695,000 | -75.1% | 64,532 | +102.3% | 0.06% | -89.0% |
| Q2 2017 | $2,788,000 | – | 31,900 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 200,000 | $20,706,000 | 6.01% |
| Redmile Group, LLC | 230,673 | $23,882,000 | 2.95% |
| WEATHERBIE CAPITAL, LLC | 241,419 | $24,994,000 | 2.31% |
| Tekla Capital Management LLC | 185,820 | $19,238,000 | 2.02% |
| Ghost Tree Capital, LLC | 25,000 | $2,588,000 | 1.59% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $588,741,000 | 1.56% |
| Iguana Healthcare Management, LLC | 25,000 | $2,588,000 | 1.48% |
| Eventide Asset Management | 42,100 | $4,359,000 | 1.34% |
| Bain Capital Public Equity Management, LLC | 401,330 | $41,550,000 | 1.17% |
| Rock Springs Capital Management LP | 31,500 | $3,261,000 | 1.16% |